Synthesis and evaluation of racemic [11C]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET

D. F. Smith, D. Bender, K. Marthi, P. Cumming, S. B. Hansen, D. Peters, E. Nielsen, J. Scheel-Krüger, A. Gjedde

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Positron emission tomography (PET) radiotracers are needed for quantifying serotonin uptake sites in the living brain. Therefore, we evaluated a new selective serotonin reuptake inhibitor, NS2456, to determine whether it is suited for use in PET. Racemic NS2456 [(1RS,5SR)-8-methyl-3-[4-trifluoromethoxyphenyl]-8-azabicyclo [3.2.1]oct-2-ene] and its N-demethylated analog, racemic NS2463, selectively inhibited serotonin uptake in rat brain synaptosomes; their IC50 values were 3000-fold lower for [3H]serotonin than for either [3H]dopamine or [3H]noradrenaline. The enantiomers of NS2463 were also potent inhibitors of serotonin uptake in vitro, but they failed to show stereoselectivity. Racemic NS2463 as well as its enantiomers were radiolabelled by N-methylation with C-11, yielding [11C]NS2456 for use in PET of the living porcine brain. The compounds crossed the blood-brain barrier rapidly and accumulated preferentially in regions rich in serotonin uptake sites (e.g., brainstem, subthalamus and thalamus). However, their binding potentials were relatively low and no stereoselectivity was found. Thus, neither racemic [11C]NS2456 nor its [11C]-labelled enantiomers are ideal for PET neuroimaging of neuronal serotonin uptake sites.

Original languageEnglish
Pages (from-to)265-270
Number of pages6
JournalNuclear Medicine and Biology
Volume28
Issue number3
DOIs
Publication statusPublished - 2001

Fingerprint

Positron-Emission Tomography
Serotonin
Serotonin Uptake Inhibitors
Brain
Subthalamus
Synaptosomes
Blood-Brain Barrier
Thalamus
Neuroimaging
Methylation
Inhibitory Concentration 50
Brain Stem
Dopamine
Norepinephrine
Swine
NS 2456

Keywords

  • 8-azabicyclo[3.2.1]oct-2-ene
  • [C]NS2456
  • Chiral resolution
  • PET
  • Selective serotonin reuptake inhibitor

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Synthesis and evaluation of racemic [11C]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET. / Smith, D. F.; Bender, D.; Marthi, K.; Cumming, P.; Hansen, S. B.; Peters, D.; Nielsen, E.; Scheel-Krüger, J.; Gjedde, A.

In: Nuclear Medicine and Biology, Vol. 28, No. 3, 2001, p. 265-270.

Research output: Contribution to journalArticle

Smith, DF, Bender, D, Marthi, K, Cumming, P, Hansen, SB, Peters, D, Nielsen, E, Scheel-Krüger, J & Gjedde, A 2001, 'Synthesis and evaluation of racemic [11C]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET', Nuclear Medicine and Biology, vol. 28, no. 3, pp. 265-270. https://doi.org/10.1016/S0969-8051(00)00175-X
Smith, D. F. ; Bender, D. ; Marthi, K. ; Cumming, P. ; Hansen, S. B. ; Peters, D. ; Nielsen, E. ; Scheel-Krüger, J. ; Gjedde, A. / Synthesis and evaluation of racemic [11C]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET. In: Nuclear Medicine and Biology. 2001 ; Vol. 28, No. 3. pp. 265-270.
@article{77882cf30eac4ed288fa76c97b82a7f1,
title = "Synthesis and evaluation of racemic [11C]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET",
abstract = "Positron emission tomography (PET) radiotracers are needed for quantifying serotonin uptake sites in the living brain. Therefore, we evaluated a new selective serotonin reuptake inhibitor, NS2456, to determine whether it is suited for use in PET. Racemic NS2456 [(1RS,5SR)-8-methyl-3-[4-trifluoromethoxyphenyl]-8-azabicyclo [3.2.1]oct-2-ene] and its N-demethylated analog, racemic NS2463, selectively inhibited serotonin uptake in rat brain synaptosomes; their IC50 values were 3000-fold lower for [3H]serotonin than for either [3H]dopamine or [3H]noradrenaline. The enantiomers of NS2463 were also potent inhibitors of serotonin uptake in vitro, but they failed to show stereoselectivity. Racemic NS2463 as well as its enantiomers were radiolabelled by N-methylation with C-11, yielding [11C]NS2456 for use in PET of the living porcine brain. The compounds crossed the blood-brain barrier rapidly and accumulated preferentially in regions rich in serotonin uptake sites (e.g., brainstem, subthalamus and thalamus). However, their binding potentials were relatively low and no stereoselectivity was found. Thus, neither racemic [11C]NS2456 nor its [11C]-labelled enantiomers are ideal for PET neuroimaging of neuronal serotonin uptake sites.",
keywords = "8-azabicyclo[3.2.1]oct-2-ene, [C]NS2456, Chiral resolution, PET, Selective serotonin reuptake inhibitor",
author = "Smith, {D. F.} and D. Bender and K. Marthi and P. Cumming and Hansen, {S. B.} and D. Peters and E. Nielsen and J. Scheel-Kr{\"u}ger and A. Gjedde",
year = "2001",
doi = "10.1016/S0969-8051(00)00175-X",
language = "English",
volume = "28",
pages = "265--270",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Synthesis and evaluation of racemic [11C]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET

AU - Smith, D. F.

AU - Bender, D.

AU - Marthi, K.

AU - Cumming, P.

AU - Hansen, S. B.

AU - Peters, D.

AU - Nielsen, E.

AU - Scheel-Krüger, J.

AU - Gjedde, A.

PY - 2001

Y1 - 2001

N2 - Positron emission tomography (PET) radiotracers are needed for quantifying serotonin uptake sites in the living brain. Therefore, we evaluated a new selective serotonin reuptake inhibitor, NS2456, to determine whether it is suited for use in PET. Racemic NS2456 [(1RS,5SR)-8-methyl-3-[4-trifluoromethoxyphenyl]-8-azabicyclo [3.2.1]oct-2-ene] and its N-demethylated analog, racemic NS2463, selectively inhibited serotonin uptake in rat brain synaptosomes; their IC50 values were 3000-fold lower for [3H]serotonin than for either [3H]dopamine or [3H]noradrenaline. The enantiomers of NS2463 were also potent inhibitors of serotonin uptake in vitro, but they failed to show stereoselectivity. Racemic NS2463 as well as its enantiomers were radiolabelled by N-methylation with C-11, yielding [11C]NS2456 for use in PET of the living porcine brain. The compounds crossed the blood-brain barrier rapidly and accumulated preferentially in regions rich in serotonin uptake sites (e.g., brainstem, subthalamus and thalamus). However, their binding potentials were relatively low and no stereoselectivity was found. Thus, neither racemic [11C]NS2456 nor its [11C]-labelled enantiomers are ideal for PET neuroimaging of neuronal serotonin uptake sites.

AB - Positron emission tomography (PET) radiotracers are needed for quantifying serotonin uptake sites in the living brain. Therefore, we evaluated a new selective serotonin reuptake inhibitor, NS2456, to determine whether it is suited for use in PET. Racemic NS2456 [(1RS,5SR)-8-methyl-3-[4-trifluoromethoxyphenyl]-8-azabicyclo [3.2.1]oct-2-ene] and its N-demethylated analog, racemic NS2463, selectively inhibited serotonin uptake in rat brain synaptosomes; their IC50 values were 3000-fold lower for [3H]serotonin than for either [3H]dopamine or [3H]noradrenaline. The enantiomers of NS2463 were also potent inhibitors of serotonin uptake in vitro, but they failed to show stereoselectivity. Racemic NS2463 as well as its enantiomers were radiolabelled by N-methylation with C-11, yielding [11C]NS2456 for use in PET of the living porcine brain. The compounds crossed the blood-brain barrier rapidly and accumulated preferentially in regions rich in serotonin uptake sites (e.g., brainstem, subthalamus and thalamus). However, their binding potentials were relatively low and no stereoselectivity was found. Thus, neither racemic [11C]NS2456 nor its [11C]-labelled enantiomers are ideal for PET neuroimaging of neuronal serotonin uptake sites.

KW - 8-azabicyclo[3.2.1]oct-2-ene

KW - [C]NS2456

KW - Chiral resolution

KW - PET

KW - Selective serotonin reuptake inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0035027769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035027769&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(00)00175-X

DO - 10.1016/S0969-8051(00)00175-X

M3 - Article

C2 - 11323236

AN - SCOPUS:0035027769

VL - 28

SP - 265

EP - 270

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 3

ER -